Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs for Knee Osteoarthritis
NCT06463847Phase 1Recruiting
- Start
- Jun 2024
- Primary completion
- Oct 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of human umbilical cord mesenchymal stem cells in knee osteoarthritis (OA) (3 arms). Primary endpoint: Adverse Events at 4 weeks. Started Jun 2024; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06463847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06463847.